Gain Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Gain Therapeutics Total Assets Growth & History (GANX)
Gain Therapeutics's total assets was $22.8M for fiscal 2025.
View full Gain Therapeutics company overviewGain Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $22.8M | $10.7M | +88.22% |
| 2024 | 2024-12-31 | $12.1M | −$6.5M | −34.85% |
| 2023 | 2023-12-31 | $18.6M | −$5.5M | −22.78% |
| 2022 | 2022-12-31 | $24.1M | −$14.9M | −38.18% |
| 2021 | 2021-12-31 | $39.0M | $29.4M | +305.91% |
| 2020 | 2020-12-31 | $9.6M | — | — |
Gain Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $15.4M | $5.6M | +56.82% |
| Q1 2026 | 2026-03-31 | $18.7M | $7.1M | +61.20% |
| Q4 2025 | 2025-12-31 | $22.8M | $10.7M | +88.22% |
| Q3 2025 | 2025-09-30 | $11.0M | −$3.4M | −23.63% |
| Q2 2025 | 2025-06-30 | $9.8M | −$9.4M | −48.77% |
| Q1 2025 | 2025-03-31 | $11.6M | −$3.0M | −20.26% |
| Q4 2024 | 2024-12-31 | $12.1M | −$6.5M | −34.85% |
| Q3 2024 | 2024-09-30 | $14.4M | $268,216 | +1.90% |
| Q2 2024 | 2024-06-30 | $19.2M | $935,313 | +5.12% |
| Q1 2024 | 2024-03-31 | $14.6M | −$6.7M | −31.63% |
| Q4 2023 | 2023-12-31 | $18.6M | −$5.5M | −22.78% |
| Q3 2023 | 2023-09-30 | $14.1M | −$14.2M | −50.23% |
| Q2 2023 | 2023-06-30 | $18.3M | −$13.6M | −42.74% |
| Q1 2023 | 2023-03-31 | $21.3M | −$16.3M | −43.29% |
| Q4 2022 | 2022-12-31 | $24.1M | −$14.9M | −38.18% |
| Q3 2022 | 2022-09-30 | $28.3M | −$14.2M | −33.45% |
| Q2 2022 | 2022-06-30 | $31.9M | −$13.5M | −29.68% |
| Q1 2022 | 2022-03-31 | $37.6M | −$10.4M | −21.74% |
| Q4 2021 | 2021-12-31 | $39.0M | $29.4M | +305.91% |
| Q3 2021 | 2021-09-30 | $42.6M | — | — |
| Q2 2021 | 2021-06-30 | $45.4M | — | — |
| Q1 2021 | 2021-03-31 | $48.0M | — | — |
| Q4 2020 | 2020-12-31 | $9.6M | — | — |
Gain Therapeutics total assets trends
Over the last five fiscal years, Gain Therapeutics's total assets increased from $9.6M to $22.8M, a change of $13.2M. The latest reported quarter, Q2 2026, shows $15.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gain Therapeutics source filings ↗